# Revatio

NDC: 58151-395
Generic name: sildenafil citrate
Labeler / Manufacturer: Viatris Specialty LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250409

FDA application: NDA022473

## Active ingredients

- SILDENAFIL CITRATE: .8 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58151-395"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58151-395
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bb9363e-b28d-4019-8aae-539233dca214